

| Número de catálogo | DS856018 |
|---|---|
| Descripción |
Afasevikumab ELISA Kit (DS856018) — Quantitative sandwich ELISA for Afasevikumab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
|
| Tipo de muestra | Plasma, Serum |
| Sensibilidad | 0.156 μg/ml |
| Rango | 0.31-5 μg/mL |
| Número de acceso | Q16552 & Q96PD4 |
| Aplicaciones | ELISA |
| Método de detección | Colorimetric |
| Tipo de ensayo | Quantitative |
| Recuperación | 80-120% |
| Envío | 2-8 ℃ |
| Estabilidad y almacenamiento | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| Especificaciones | Afasevikumab |
| Nombres alternativos | MCAF-5352A, MCAF5352A, NI-1401, RG-7624, RG7624, RO5553110, 1589503-30-9 |
| Fondo | Afasevikumab, also known as RG7624, is a human antibody inhibitor for human interleukin 17A (IL17A) and interleukin 17F (IL17F). This drug was developed by Genentech and has been investigated in the study of the treatment of inflammation diseases like autoimmune disorders. In 2013, Genentech completed a phase Ib study for the treatment of autoimmune disorders in Canada. However, it had been discontinued in 2015. In 2016, researchers used afasevikumab to conduct a phase I clinical trials for the treatment of inflammation in USA with no specified. |
| Nota | For Research Use Only. |

Standard Curve of Afasevikumab ELISA Kit
Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.
Correo: [email protected]


+86-027-65523339
Edificio C, No. 666, Calle Shendunsi, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский